These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
586 related articles for article (PubMed ID: 24882207)
21. RNA binding of PRC2: promiscuous or well ordered? Kretz M; Meister G Mol Cell; 2014 Jul; 55(2):157-8. PubMed ID: 25038410 [TBL] [Abstract][Full Text] [Related]
22. Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer. Martin MC; Zeng G; Yu J; Schiltz GE J Med Chem; 2020 Dec; 63(24):15344-15370. PubMed ID: 33283516 [TBL] [Abstract][Full Text] [Related]
23. Elements of the polycomb repressor SU(Z)12 needed for histone H3-K27 methylation, the interface with E(Z), and in vivo function. Rai AN; Vargas ML; Wang L; Andersen EF; Miller EL; Simon JA Mol Cell Biol; 2013 Dec; 33(24):4844-56. PubMed ID: 24100017 [TBL] [Abstract][Full Text] [Related]
24. Structures of human PRC2 with its cofactors AEBP2 and JARID2. Kasinath V; Faini M; Poepsel S; Reif D; Feng XA; Stjepanovic G; Aebersold R; Nogales E Science; 2018 Feb; 359(6378):940-944. PubMed ID: 29348366 [TBL] [Abstract][Full Text] [Related]
25. G-quadruplex folding in Xist RNA antagonizes PRC2 activity for stepwise regulation of X chromosome inactivation. Lee YW; Weissbein U; Blum R; Lee JT Mol Cell; 2024 May; 84(10):1870-1885.e9. PubMed ID: 38759625 [TBL] [Abstract][Full Text] [Related]
26. Identification of catalytic and non-catalytic activity inhibitors against PRC2-EZH2 complex through multiple high-throughput screening campaigns. Zhou Y; Du DH; Wang J; Cai XQ; Deng AX; Nosjean O; Boutin JA; Renard P; Yang DH; Luo C; Wang MW Chem Biol Drug Des; 2020 Oct; 96(4):1024-1051. PubMed ID: 32394628 [TBL] [Abstract][Full Text] [Related]
34. Polycomb repressive complex 2 regulates normal development of the mouse heart. He A; Ma Q; Cao J; von Gise A; Zhou P; Xie H; Zhang B; Hsing M; Christodoulou DC; Cahan P; Daley GQ; Kong SW; Orkin SH; Seidman CE; Seidman JG; Pu WT Circ Res; 2012 Feb; 110(3):406-15. PubMed ID: 22158708 [TBL] [Abstract][Full Text] [Related]
35. Live-cell imaging reveals the dynamics of PRC2 and recruitment to chromatin by SUZ12-associated subunits. Youmans DT; Schmidt JC; Cech TR Genes Dev; 2018 Jun; 32(11-12):794-805. PubMed ID: 29891558 [TBL] [Abstract][Full Text] [Related]
36. Polycomb repressive complex 2 is required for MLL-AF9 leukemia. Neff T; Sinha AU; Kluk MJ; Zhu N; Khattab MH; Stein L; Xie H; Orkin SH; Armstrong SA Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5028-33. PubMed ID: 22396593 [TBL] [Abstract][Full Text] [Related]
37. Structure of the catalytic domain of EZH2 reveals conformational plasticity in cofactor and substrate binding sites and explains oncogenic mutations. Wu H; Zeng H; Dong A; Li F; He H; Senisterra G; Seitova A; Duan S; Brown PJ; Vedadi M; Arrowsmith CH; Schapira M PLoS One; 2013; 8(12):e83737. PubMed ID: 24367611 [TBL] [Abstract][Full Text] [Related]
38. A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention. Svrlanska A; Reichel A; Schilling EM; Scherer M; Stamminger T; Reuter N J Virol; 2019 May; 93(9):. PubMed ID: 30814291 [TBL] [Abstract][Full Text] [Related]
39. A monoclonal antibody raised against human EZH2 cross-reacts with the RNA-binding protein SAFB. Cherney RE; Mills CA; Herring LE; Braceros AK; Calabrese JM Biol Open; 2023 Jun; 12(6):. PubMed ID: 37283223 [TBL] [Abstract][Full Text] [Related]